Fullerton Healthcare Corporation Limited, a leading vertically integrated healthcare platform in Asia Pacific, announced that Fullerton Health China Limited ("Fullerton China") has completed an equity investment of RMB300 million in Shanghai Redleaf International Women's & Children's Hospital ("Redleaf Hospital"). This is Fullerton China's first investment in the specialty hospitals sector, following which Fullerton China will become a key strategic shareholder of Redleaf Hospital. 

The investment in Redleaf Hospital is an important step that demonstrates Fullerton China's commitment to the domestic healthcare market. In May 2018, Fullerton China acquired a majority stake in Jiangsu Kangruijia Medical Investment Management Co., Ltd ("Global Doctor"), a leading primary care clinic group in China with healthcare services network of eighteen clinics.

This strategic investment from Fullerton China provides Redleaf Hospital with an even stronger platform for future growth. Redleaf Hospital, which currently focuses on pediatrics, obstetrics and gynecology, will expand into a multi-specialty hospital covering other specialties such as orthopedics and ophthalmology.

Fullerton Health and Fullerton China will leverage their deep sector expertise, established over years of operating professional healthcare institutions across the Asia Pacific region, to guide the successful implementation of Redleaf Hospital's expansion plan. A new upgraded hospital is expected to open at the end of 2019.

Additionally, Fullerton China and Redleaf Hospital also plan to jointly invest RMB200 million to set up a chain of primary care clinics in Shanghai. Through leveraging Fullerton Health's resources and expertise in healthcare centre operation and management, the clinics will provide GP, specialist outpatient, health screening and other services, which are consistent with the Chinese government's plans to establish an effective and multi-tiered healthcare system in the country.